LINTEX
920106
LINGOOD
833284
NTGEC
870436
CG MED EQUIP.
838810
Jiayu Holding
300117
CN Stock MarketDetailed Quotes
300677 Intco Medical Technology
- 24.75
- -0.46-1.82%
Market Closed Feb 28 15:00 CST
15.99BMarket Cap21.62P/E (TTM)
25.46High24.67Low129.98KlotVolume25.25Open25.21Pre Close326.14MTurnover2.77%Turnover Ratio41.74P/E (Static)646.19MShares33.5652wk High0.96P/B11.61BFloat Cap19.4852wk Low30.25Limit Up469.04MShs Float164.14Historical High20.17Limit Down3.13%Amplitude2.14Historical Low0.13Dividend TTM25.09Avg Price69.06KlotAsk0.53%Div YieldTTM100Lot Size53.76KlotBid
Intco Medical Technology News
Investors Aren't Entirely Convinced By Intco Medical Technology Co., Ltd.'s (SZSE:300677) Earnings
Can Mixed Fundamentals Have A Negative Impact on Intco Medical Technology Co., Ltd. (SZSE:300677) Current Share Price Momentum?
Intco Medical Technology (300677.SZ): has cumulatively repurchased 0.3033 million shares.
On February 5, Gelonghui reported that Intco Medical Technology (300677.SZ) announced that as of January 31, 2025, the company has repurchased a total of 0.3033 million shares through a special securities account for share buybacks via centralized bidding trading, accounting for 0.0469% of the company's total share capital (based on a total share capital of 646,193,496 shares as of January 27, 2025). The highest Fill Price was 21.62 yuan/share, the lowest Fill Price was 20.99 yuan/share, and the total amount of the transaction was 6.4676 million yuan (excluding transaction costs).
Intco Medical Technology (300677.SZ) announced an earnings forecast, expecting net income for the year 2024 to be between 1.2 billion and -1.5 billion yuan, representing a significant year-on-year growth of 213.32% to 291.65%.
Intco Medical Technology (300677.SZ) released its performance forecast for 2024, with the company expecting...
British Healthcare: 2024 Annual Results Forecast
Is Intco Medical Technology (SZSE:300677) A Risky Investment?
Intco Medical Technology's (SZSE:300677) Five-year Total Shareholder Returns Outpace the Underlying Earnings Growth
Fewer Investors Than Expected Jumping On Intco Medical Technology Co., Ltd. (SZSE:300677)
Intco Medical Technology (300677.SZ): The cumulative repurchased 0.3033 million shares.
Intco Medical Technology (300677.SZ) announced that, as of October 31, 2024, the company has repurchased a total of 303,300 shares through a share repurchase dedicated securities account via centralized auction trading, accounting for 0.0469% of the total share capital (based on the total share capital of 646,185,763 shares as of October 31, 2024). The highest fill price was 21.62 yuan/share, the lowest fill price was 20.99 yuan/share, and the total fill amount was RMB 6,467,649.00 (excluding trading expenses).
British Healthcare: Report for the third quarter of 2024
Express News | Intco Medical Technology Says Q3 Net Profit up 166.5% Y/Y
Individual Investors Invested in Intco Medical Technology Co., Ltd. (SZSE:300677) up 5.9% Last Week, Insiders Too Were Rewarded
Intco Medical Technology Co., Ltd.'s (SZSE:300677) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Selected Announcement: Oulai New Materials: plans to invest no less than 2.59 billion yuan to build the Oulai New Materials Mingyue Lake Industrial Park project; Intco Medical Technology: plans to repurchase company shares worth 80 million to 0.12 billion
Beijing Tianyishangjia New Material Corp.: Tianrendahe intends to cooperate with Xinghe Power in the research and development and manufacturing of solid and liquid launch vehicle related components.
GLE.FE Announcement Selection | Oulai New Materials: Intends to invest no less than 2.59 billion yuan to build Oulai New Materials Mingyue Lake Industrial Park project; Intco Medical Technology: Intends to repurchase company shares worth 80 million yuan t
[Company Business Data] Yunda Holding (002120.SZ): In August, the express service business income was 3.917 billion yuan, a year-on-year increase of 11.41%. sto express co.,ltd. (002468.SZ): In August, the express service business income was 3.873 billion yuan, a year-on-year increase of 21.5%. YTO Express Group (600233.SH): In August, the express product income was 4.908 billion yuan, a year-on-year increase of 20.67%. guilin layn natural ingredients corp. (002166.SZ): Net income is expected to increase by 100%-150% in the first three quarters. [Contract Projects] Oulei New Materials (688530.SH): Intends to be no less than 2.59 billion.
intco medical technology (300677.SZ): plans to repurchase company shares worth 80 million to 0.12 billion yuan.
On September 19, Intco Medical Technology (300677.SZ) announced that it plans to repurchase a total amount of shares not less than RMB 80 million and not exceeding RMB 120 million, with a maximum repurchase price of RMB 26.66 per share, for the purpose of implementing employee stock ownership plans and/or stock-based incentives.
The threat of additional tariffs looms high, intco medical technology's stock price drops by 20%, What are the prospects for its North American layout?
①Today, Intco Medical Technology's stock fell 20 centimeters in the intraday trading session. An employee from the securities department of Intco Medical Technology stated, 'This is because the United States announced the impact of increasing tariffs on some Chinese commodities under Section 301.' ②The employee said that the proportion of the U.S. market in the company's revenue is about 35%, which may pose challenges to the company's performance in the short term. However, the overall potential of the U.S. market is still significant, and the company still plans to increase its efforts to expand into the North American market.
Solid Earnings May Not Tell The Whole Story For Intco Medical Technology (SZSE:300677)
Intco Medical Technology (SZSE:300677) May Have Issues Allocating Its Capital
British Healthcare: 2024 Semi-Annual Report Summary
